Manish Kumar Choudhary
Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai
Papers
3
Total Citations
11
H-Index
2
About
Dr. Manish Kumar Choudhary is a rising leader in urologic oncology and minimally invasive surgery, whose work is reshaping the management of benign prostatic hyperplasia (BPH) and prostate cancer. His research centers on optimizing surgical techniques and integrating advanced diagnostics to improve patient outcomes. Dr. Choudhary’s landmark 2024 study, with 8 citations, provides a pivotal propensity-matched comparison of en-bloc holmium laser enucleation (HoLEP) and robot-assisted simple prostatectomy (RASP), establishing evidence-based benchmarks for treating medication-refractory BPH. He is also a key innovator in the “hood technique” for robotic radical prostatectomy, a modification designed to preserve anterior urethral structures and accelerate postoperative recovery. Beyond the operating room, Dr. Choudhary is advancing precision oncology; his 2025 predictive model integrates genomic classifiers with nonsuspicious MRI findings to forecast lymph node metastasis in localized prostate cancer, offering a nuanced tool to guide surgical planning. With a growing citation impact and a focus on both technical refinement and data-driven decision-making, Dr. Choudhary is at the forefront of a new era in urologic care—where surgical excellence meets personalized medicine.
Research Focus
Key Achievements
Top Papers
- 1
- 2Hood Technique for Radical Prostatectomy2 citations · 2025
- 3